The Vutrisiran market can be segmented by drug class, route of administration, and therapeutic application. Currently, the "Injectable" segment dominates the market, as the drug's formulation is specifically optimized for subcutaneous delivery. However, within the therapeutic segments, the "Cardiovascular" application is rapidly outpacing the "Neurological" segment following recent label...